INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 325
RESEARCH DOSSIER / NOT AN ENDORSEMENT

WellieMD

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'The White-Label Telehealth Platform to Launch and Scale Your Brand.'

Audienceread

Founders and clinicians launching GLP-1/hormone/longevity brands.

Pricing & termspartial

Not published on reviewed pages.

Clinical relationshipspartial

'Launch GLP-1, hormone, TRT, peptide and longevity programs under your own name.' Licensed providers, brand-name and compounded pharmacy pathways, subscriptions and refills on one platform. Founded by a licensed clinician (27 years in healthcare).

Pharmacy & fulfillmentpartial

Brand-name and compounded pharmacy pathways.

Advertising snapshotpartial

Google: No ads found for welliemd.com (US, last 30 days, 20 Oct 2026). Meta: Meta Ad Library keyword lookup for 'welliemd.com' displayed ~3 results on 20 Oct 2026. LinkedIn: LinkedIn Ad Library returned 'No results found' on 20 Oct 2026.

Founding yearnot_found

Not established in this pass.

    Foundersnot_found

    Not established in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.